Your browser doesn't support javascript.
loading
Roles of VGLUT2 and Dopamine/Glutamate Co-Transmission in Selective Vulnerability to Dopamine Neurodegeneration.
Buck, Silas A; Erickson-Oberg, M Quincy; Bhatte, Sai H; McKellar, Chase D; Ramanathan, Vishan P; Rubin, Sophie A; Freyberg, Zachary.
Afiliação
  • Buck SA; Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.
  • Erickson-Oberg MQ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.
  • Bhatte SH; Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.
  • McKellar CD; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.
  • Ramanathan VP; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.
  • Rubin SA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.
  • Freyberg Z; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.
ACS Chem Neurosci ; 13(2): 187-193, 2022 01 19.
Article em En | MEDLINE | ID: mdl-34994539
Growing evidence has established that a subset of dopamine (DA) neurons co-release glutamate and express vesicular glutamate transporter 2 (VGLUT2). VGLUT2 expression in DA neurons plays a key role in selective vulnerability to DA neurodegeneration in Parkinson's disease (PD). In this review, we summarize recent findings on impacts of VGLUT2 expression and glutamate co-release from DA neurons on selective DA neuron vulnerability. We present evidence that DA neuron VGLUT2 expression may be neuroprotective, boosting DA neuron resilience in the context of ongoing neurodegenerative processes in PD. We highlight genetic and pesticide models of PD that have provided mechanistic insights into selective DA neuron vulnerability. Finally, we discuss potential neuroprotective mechanisms, focusing on roles of VGLUT2 and glutamate in promoting mitochondrial health and diminishing oxidative stress and excitotoxicity. Elucidating these mechanisms may ultimately lead to more effective treatments to boost DA neuron resilience that can slow or even prevent DA neurodegeneration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Dopamina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Dopamina Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos